Mutation screening of the CARD15 gene in sarcoidosis

Tissue Antigens

Volumn 71, Issue 6, 2008, Pages 564-567

  Akahoshi, M ^a,b,c   Ishihara, M ^d,e   Namba, K ^f   Kitaichi, N ^f   Ando, Y ^g   Takenaka, S ^h   Ishida, T ^e   Ohno, S ^f   Mizuki, N ^d   Nakashima, H ^b,i   Shirakawa, T ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c CHIHAYA HOSPITAL   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e Hiyoshi Ophthalmic Clinic   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h KUMAMOTO CITY HOSPITAL   (Japan)

ⁱ FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blau syndrome; CARD15; Crohn's disease; Early onset sarcoidosis; Mutation; Sarcoidosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLAU SYNDROME; CARD15 GENE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE; GENE MUTATION; GENETIC RISK; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SARCOIDOSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CROHN DISEASE; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POINT MUTATION; RISK FACTORS; SARCOIDOSIS;

EID: 43849093322     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01043.x     Document Type: Article

References (24)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997 : 336 : 1224 34.
2. Akahoshi M, Ishihara M, Remus N et al. Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 2004 : 114 : 503 9.
3. Rossman MD, Thompson B, Frederick M et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003 : 73 : 720 35.
4. Valentonyte R, Hampe J, Huse K et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005 : 37 : 357 64.
5. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007 : 357 : 2153 65.
6. Shetty AK, Gedalia A. Sarcoidosis: a pediatric perspective. Clin Pediatr (Phila) 1998 : 37 : 707 17.
7. Tromp G, Kuivaniemi H, Raphael S et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 1996 : 59 : 1097 107.
8. Miceli-Richard C, Lesage S, Rybojad M et al. CARD15 mutations in Blau syndrome. Nat Genet 2001 : 29 : 19 20.
9. Kanazawa N, Okafuji I, Kambe N et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 2005 : 105 : 1195 7.
10. Inoue N, Tamura K, Kinouchi Y et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002 : 123 : 86 91.
11. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002 : 47 : 469 72.
12. Lesage S, Zouali H, Cezard JP et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002 : 70 : 845 57.
13. Arostegui JI, Arnal C, Merino R et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 2007 : 56 : 3805 13.
14. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 : 411 : 603 6.
15. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 : 411 : 599 603.
16. Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J 2003 : 22 : 748 54.
17. Ho LP, Merlin F, Gaber K, Davies RJ, McMichael AJ, Hugot JP. CARD 15 gene mutations in sarcoidosis. Thorax 2005 : 60 : 354 5.
18. Martin TM, Doyle TM, Smith JR, Dinulescu D, Rust K, Rosenbaum JT. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 2003 : 136 : 933 5.
19. Milman N, Nielsen OH, Hviid TV, Fenger K. CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration 2007 : 74 : 76 9.
20. Gazouli M, Koundourakis A, Ikonomopoulos J et al. CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006 : 23 : 23 9.
21. Kambe N, Nishikomori R, Kanazawa N. The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders. J Dermatol Sci 2005 : 39 : 71 80.
22. Tanabe T, Ishige I, Suzuki Y et al. Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochim Biophys Acta 2006 : 1762 : 794 801.
23. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 2006 : 367 : 1271 84.
24. Croucher PJ, Mascheretti S, Hampe J et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003 : 11 : 6 16.